BGI Genomics Co., Ltd. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 4,514 million compared to CNY 5,152.04 million a year ago. Revenue was CNY 4,514 million compared to CNY 5,152.04 million a year ago.

Net income was CNY 747.34 million compared to CNY 1,414.23 million a year ago. Basic earnings per share from continuing operations was CNY 1.8279 compared to CNY 3.4586 a year ago. Diluted earnings per share from continuing operations was CNY 1.8276 compared to CNY 3.4402 a year ago.